ACSH Science Dispatch Podcast

Volcanic eruptions cool the earth by "shading" the atmosphere with particles. What if we used giant balloons to similar effect?

Tort lawyers regularly bring litigation against pesticide companies, alleging that their products cause devastating diseases. Of course, our genetic makeup profoundly influences our risk for certain medical conditions, including those allegedly caused by pesticide exposure. Yet this reality rarely gets the attention it deserves in court. Let's take a closer look at the science the lawyers would rather ignore.

Lars Larson and I discussed on his program the distinction between eradicating and controlling viruses and the complexities of virus management posed by different viral characteristics.

Microplastics are everywhere, including in your arteries, and they heighten your heart attack risk! So declared a slew of recent headlines reporting on a study in the New England Journal of Medicine. Let's examine all the science reporters ignored in their rush to get hyperbolic stories out the door.

Lars Larson and I discussed on his program the Oscar-winning film about Robert Oppenheimer, the father of the atomic bomb.

A recent study found that controlled periods of fasting could hold the key to unlocking a longer, healthier life. Do we finally have evidence that skipping meals reverses aging, or is the situation more complicated than that?

In a recent conversation with John Batchelor (CBS "Eye on the World"), we explored the resurgence of measles amidst a wave of vaccine hesitancy sparked by the COVID-19 pandemic.

Artificial Intelligence plays an increasingly prominent role in modern life, medicine included. While the technology promises to improve health care in many ways, it also carries potentially serious risks. That raises a critical question: when AI harms patients, who's responsible?

Tinnitus – a vexing ringing in one or both of your ears not caused by external sound – impacts some 740 million adults globally. A recently FDA-approved treatment appears poised to help many of these patients reduce the severity of their symptoms and thereby boost their quality of life. Let's take a closer look at this therapy to find out how it works.

The standard argument for restricting patient access to pain medications is that these drugs frequently lead to addiction. A large body of research contradicts that claim, though it's doubly absurd when directed at people afflicted by terminal (and often very painful) illnesses. They sometimes have only weeks or months to live, yet they're denied pain medicine in the name of fighting opioid dependence. Such absurdity has to stop.